Afeditab (Nifedipine) - Summary

AFEDITAB SUMMARY

CP0346B
Afeditab^® CR
(Nifedipine Extended-Release Tablets)
Revised: July 2005
Rx only

Afeditab^® CR is an extended release tablet dosage form of the calcium channel blocker nifedipine.

Afeditab^® CR is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

AFEDITAB NEWS HIGHLIGHTS

Published Studies Related to Afeditab (Nifedipine)

Nifedipine as a Uterine Relaxant for External Cephalic Version: A Randomized Controlled Trial. [2008.08]

Efficacy of nitroglycerine infusion versus sublingual nifedipine in severe pre-eclampsia: a randomized, triple-blind, controlled trial. [2008.05]

Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients. [2008.05]

Terbutaline versus nifedipine for prolongation of pregnancy in patients with preterm labor. [2008.01]

EFFICACY OF NITROGLYCERINE INFUSION VERSUS SUBLINGUAL NIFEDIPINE IN SEVERE PRE-ECLAMPSIA: A RANDOMIZED, TRIPLE-BLIND, CONTROLLED TRIAL. [2007.12.07]

more>>

Clinical Trials Related to Afeditab (Nifedipine)

Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery [Not yet recruiting]

A Study of Nifecardia SRFC and Adalat OROS in the Treatment of Patients With Essential Hypertension [Not yet recruiting]

Losartan Therapy in Pulmonary Hypertension [Completed]

Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis [Completed]

Indomethacin Versus Nifedipine for Preterm Labor Tocolysis [Recruiting]

more>>